Beyond the Scale: How the GLP-1 Boom is Reshaping Diets, Wallets, and Industries
The surge in popularity of weight-loss drugs like Ozempic and Wegovy is sending shockwaves far beyond the pharmacy, fundamentally altering consumer spending, challenging major corporations, and forcing a broad economic recalibration.